About UsMembershipMarketplaceResourcesGlobal Business Atlas
Top AI CompaniesTop Blockchain Influencers & AuthorsTop Global Digital AgenciesBusinessabc Country IndexesTop Accelerators and Chambers of CommerceTop Public Companies by MarketcapBusinessabc Education IndexesTop Malaysian Companies
DirectoryCompaniesLeadersInvestorsUniversitiesOrganisations
Loading wiki page…

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More
Last Updated: 2026
PainReform image

PainReform

Rank#11109
Market Cap3.22M
CountryIsrael
Summary
History
Mission
Vision
References
Summaryarrow
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
Historyarrow

PainReform was founded in 2002 by Roger and Joni Park. Initially focusing on OTC medications, the company soon shifted to developing evidence-based prescription medication therapies for chronic pain, specifically to treat migraine headaches. After submitting a successful Investigational New Drug Application to the FDA in 2007, PainReform began multiple clinical trials and became the first to market prescription medications for the prevention of migraine headaches.

Missionarrow
PainReform is committed to developing safe, effective and accessible treatments and therapies for chronic pain syndromes. We strive to apply the latest medical research and technology to create innovative approaches to managing pain.
Visionarrow
PainReform seeks to become the preeminent provider of relief from chronic pain, to improve the quality of life for those suffering from its debilitating effects.
Referencesarrow

https://in.investing.com/equities/painreform-ltd

https://finance.yahoo.com/quote/PRFX/profile?p=PRFX

https://www.crunchbase.com/organization/painreform

https://companiesmarketcap.com/

https://www.painreform.com

Share

Leadership team
D
Dr. Sigal Aviel (Chief Operating Officer)
M
Mr. Ilan Hadar M.B.A., MBA (CEO & CFO)
D
Dr. Ehud Geller Ph.D. (Exec. Chairman)
Products / Services
Biopharma, Biotechnology, Pharmaceutical
Address
Herzliya, Tel Aviv, Israel
Established
2007-01-01
Company Registration
SEC CIK number: 0001801834
Traded as
PRFX
Website
https://www.painreform.com
Last Updated: 2026
Logo

Businessabc provides digital business directory, digital blockchain AI certification, resources, and marketplace for businesses, organisations, and professionals.

Contacts

Email
Contact

Follow Us

Created Produced

Partner logo
Partner logo

Tech AI Media Platforms

Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo

Copyright 2026 © Businessabc powered by

Powered by ztudium group

DisclaimerPrivacy PolicyTerms of Service
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo